… -19. In the current report, we summarize the peer-reviewed and preprint literature on
cardiovascular risks and complications associated with COVID-19, as well as provide insights into …

… However, it is crucial for clinicians working with cardiovascular … risk factors for COVID-19
infection. Therefore, this study characterizes the cardiovascular (CV) risk profile of COVID-19 …

… clinical and biomedical literature on cardiovascular risks of COVID-19. … to cardiovascular
comorbidities and outcomes. Finally, we discuss various cardiac manifestations of COVID-19. …

… metabolic demand, and procoagulant activity likely account for some of the increased risk
of adverse outcomes in those with COVID-19-related cardiovascular disease (CVD) [8,9,14]. …

… COVID-19, CVD, or cardiovascular risk factors. For the second objective, the exposure was
COVID-19 and a … The outcomes were any incident cardiovascular or cerebrovascular events …

… a high prevalence of cardiovascular disease risk factors in COVID-19 patients, this study …
This study is limited by the use of medication as surrogate for cardiovascular risk factors. …

… been reported in patients with Coronavirus disease 2019 (COVID-19) who experienced
adverse … between cardiovascular risk factors and in-hospital mortality in patients with COVID-19. …

… acquiring or worsening COVID-19. In conclusion, COVID-19 and related cardio-renal-pulmonary
damage can profoundly affect cardiovascular risk management of people with diabetes. …

… potentially leading to a reduced risk of complications in the setting of COVID-19. … COVID-19
had a high prevalence of cardiovascular risk factors and disease. Pre-existing cardiovascular …

… worse long-term COVID complications, including depression, … risk. Here, we summarize
the current state of knowledge about the interplay between COVID-19, depression, and CV risk …